Lipoatrophy: Clinical Trials

10 trials for Lipoatrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 unknown. 3 Not applicable, 3 Phase 4, 2 Phase 1, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Unknown 1
Phase 43Completed 3
Phase 12Completed 2
Phase 32Completed 1, Unknown 1
Phase 21Completed 1

Follow Lipoatrophy: new trials by email Literature Review of Lipoatrophy trials Research Report on Lipoatrophy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Subdermal Implant "Algeness"
Algeness Subdermal Implant (Agarose) - Skin Aging, Facial Wrinkles
Not applicableCompletedEstelab Clinic402024-06-082026-06-01
Safety and Efficacy of Injectable Poly-L-Lactic Acid for Volume Loss in the Temples Using Dual Plane Injections
Sculptra aesthetic - Lipoatrophy, Aging
Not applicableUnknownSadick Research Group202022-11-012022-11-08
Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH.
Berberine, Placebo - Metabolic Syndrome, HIV-1-infection
Phase 3UnknownHospital Civil de Guadalajara402021-04-012021-04-26
Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
Apidra, current insulin - Type 1 Diabetes, Lipoatrophy
Phase 4CompletedKinderkrankenhaus auf der Bult142016-09-012024-10-15
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
TAT4 Gel concentration A, TAT4 Gel concentration B, Placebo - Nasolabial Folds, Lipoatrophy
Phase 1CompletedTopokine Therapeutics, Inc.162014-10-012016-01-06
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells
SVF - Lipoatrophy, Aging
Phase 1CompletedAntria62013-04-012015-01-27
Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients
EFV, LPV/r - HIV Infections, Lipoatrophy
Phase 4CompletedJuan A. Arnaiz202009-10-012014-09-18
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
NucleomaxX, NucleomaxX placebo - HIV Infections, Lipoatrophy
Phase 2 / Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1672006-09-012021-11-04
Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.
Different HAART regimens - HIV Associated Lipodystrophy Syndrome., HIV
Phase 4CompletedDanish HIV Research Group1002004-03-012005-09-05
Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy
switching; dose reduction - HIV Infections, Lipoatrophy
Not applicableCompletedHospital Clinic of Barcelona602004-01-012006-10-24

Narrower conditions

Lipodystrophy (10)  ·  HIV Infections (3)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Dyslipidemias (1)  ·  Glucose Intolerance (1)  ·  HIV-Associated Lipodystrophy Syndrome (1)  ·  Hypercholesterolemia (1)  ·  Metabolic Syndrome (1)

Broader conditions

Lipid Metabolism Disorders (10)  ·  Metabolic Diseases (10)  ·  Nutritional and Metabolic Diseases (10)  ·  Skin Diseases (10)  ·  Skin Diseases, Metabolic (10)  ·  Skin and Connective Tissue Diseases (10)  ·  Immune System Diseases (5)  ·  Blood-Borne Infections (4)  ·  Communicable Diseases (4)  ·  Genital Diseases (4)  ·  Immunologic Deficiency Syndromes (4)  ·  Infections (4)  ·  Lentivirus Infections (4)  ·  RNA Virus Infections (4)  ·  Retroviridae Infections (4)

Interventions

Berberine (1)  ·  Drug Tapering (1)  ·  insulin glulisine (1)

Sponsors

Antria (1)  ·  Danish HIV Research Group (1)  ·  Estelab Clinic (1)  ·  Hospital Civil de Guadalajara (1)  ·  Hospital Clinic of Barcelona (1)  ·  Juan A. Arnaiz (1)  ·  Kinderkrankenhaus auf der Bult (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Sadick Research Group (1)  ·  Topokine Therapeutics, Inc. (1)

Countries

United States (3)  ·  Denmark (1)  ·  Puerto Rico (1)  ·  Russia (1)  ·  Spain (1)

Top investigators

Alex Laursen, D.M., DMSc (1)  ·  Ann-Brit E Hansen, M.D. (1)  ·  Court Pedersen, Professor (1)  ·  Grace A. McComsey, MD (1)  ·  Jan Gerstoft, M.D., DMSc (1)  ·  Jose Maria Gatell (1)  ·  Judith A. Aberg, MD (1)  ·  Lars Mathiesen, M.D. DMSc (1)  ·  Niels Obel (1)  ·  Olga Kordonouri, MD (1)  ·  Shahram Rahimian, MD, PhD (1)

Results publications

PMID 20827170, PMID 27089862, PMID 32738019, PMID 37611246